Cardiovascular risk assessment required with use of TKIs for CMLDecember 29, 2015CMLPatient & Survivor Care
Nilotinib safe, effective as first-line therapy for CML-CP patients age 65 and olderDecember 18, 2015CML
Expert panel issues guidelines for treatment of hematologic cancers in pregnancyDecember 1, 2015CMLAggressive LymphomasAMLIndolent Lymphoma
NCCN unveils 'Evidence Blocks' to facilitate treatment discussionsOctober 23, 2015Multiple MyelomaPatient & Survivor CareCML
